Published in J Am Geriatr Soc on January 01, 1997
Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ (1998) 1.04
HLA-A and HLA-B transcription decrease with ageing in peripheral blood leucocytes. Clin Exp Immunol (2001) 0.83
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med (1991) 2.93
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet (2005) 2.45
Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev (1984) 2.22
The family history and inherited thrombophilia. Br J Haematol (1994) 2.03
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int (2006) 1.92
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol (1996) 1.86
Testing the fit of a regression model via score tests in random effects models. Biometrics (1995) 1.76
Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg (1994) 1.74
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. J Clin Oncol (2000) 1.72
Health care for older persons, a country profile: The Netherlands. J Am Geriatr Soc (2000) 1.56
Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis (1989) 1.48
Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol (1999) 1.44
Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation (2000) 1.42
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol (1997) 1.36
Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum (1991) 1.36
Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J Med Virol (1998) 1.34
Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J (2001) 1.28
HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics (1998) 1.25
Score test for linkage in generalized linear models. Hum Hered (2007) 1.23
Diurnal variation in lung function in subgroups from two Dutch populations: consequences for longitudinal analysis. Am J Respir Crit Care Med (1999) 1.21
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2000) 1.20
Linkage studies in autosomal dominant facioscapulohumeral muscular dystrophy. J Neurol Sci (1984) 1.19
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope. Cancer Res (1996) 1.18
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis (1986) 1.14
Cerebral microbleeds in CADASIL. Neurology (2001) 1.13
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol (1999) 1.11
HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol (1996) 1.11
Musculoskeletal disorders and disability in persons aged 85 and over: a community survey. Ann Rheum Dis (1994) 1.09
Time-dependent effects of fixed covariates in Cox regression. Biometrics (1995) 1.08
Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08
HLA-DR and -DQ gene polymorphism in West Africans is twice as extensive as in north European Caucasians: evolutionary implications. Proc Natl Acad Sci U S A (1991) 1.07
Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma. Cancer Res (1990) 1.07
Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine (1993) 1.05
The expanded null cell compartment in ageing: increase in the number of natural killer cells and changes in T-cell and NK-cell subsets in human blood. Immunology (1986) 1.04
Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ (1998) 1.04
Testing familial aggregation. Biometrics (1995) 1.02
Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation (1998) 1.01
Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol (1999) 1.01
T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements. J Immunol (1991) 1.01
Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine (1997) 1.01
Influence of non-inherited maternal HLA-DR antigens on susceptibility to rheumatoid arthritis. Ann Rheum Dis (1998) 1.00
Analysis of the renal transplant waiting list: application of a parametric competing risk method. Transplantation (1998) 1.00
Three-year follow-up of Mini-Mental State Examination score in community residents aged 85 and over. Psychol Med (1995) 0.99
Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. BMJ (1996) 0.98
Score test for age at onset genetic linkage analysis in selected sibling pairs. Stat Med (2009) 0.98
TA10 and 2B3, two new alleles in the HLA-DQ region recognized by monoclonal antibodies. Hum Immunol (1986) 0.97
HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med (1986) 0.96
Subpopulations of mononuclear cells in ageing: expansion of the null cell compartment and decrease in the number of T and B cells in human blood. Immunology (1985) 0.96
Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation (1999) 0.95
Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clin Exp Immunol (1997) 0.95
The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. Hum Immunol (2001) 0.94
Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics (1993) 0.94
Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet (1996) 0.93
Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol (1993) 0.93
Surgery groups differed in adverse outcome probabilities and can be used to adjust hospital comparisons. J Clin Epidemiol (2005) 0.93
Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation (2000) 0.92
The effect of HLA matching on kidney graft survival in separate posttransplantation intervals. Transplantation (1990) 0.92
Validation of haplotype frequency estimation methods. Hum Immunol (1998) 0.91
Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys (1999) 0.91
Nomenclature for factors of the HLA System, 1998. Hum Immunol (1999) 0.91
HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology (1987) 0.90
A monoclonal antibody detecting an HLA-DQwl-related determinant. Tissue Antigens (1985) 0.89
Nomenclature for factors of the HLA system, 2000. Hum Immunol (2001) 0.88
Prevalence of deep vein thrombosis in suspected and proven pulmonary embolism: a meta-analysis. Br J Radiol (1998) 0.88
Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals. Immunogenetics (1986) 0.87
Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost (1998) 0.87
Do noninherited maternal antigens (NIMA) enhance renal graft survival? Transpl Int (1998) 0.87
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition. Immunogenetics (1998) 0.87
Gating of the so-called 'lymphocytic' cell population for the quantification of natural killer cells (CD16+) by flow cytometry causes loss of CD16 positive cells. J Immunol Methods (1990) 0.86
HLA gene and haplotype frequencies in Dutch blood donors. Tissue Antigens (1996) 0.86
Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis. Kidney Int (1995) 0.86
Orientation of major histocompatibility (MHC) genes relative to the centromere of human chromosome 6. Clin Genet (1979) 0.86
Nomenclature for factors of the HLA System, 1996. Hum Immunol (1997) 0.86
Nomenclature for factors of the HLA system, 1996. Eur J Immunogenet (1997) 0.85
Clinical evidence for localisation of HLA proximal of chromosome 6p22. Lancet (1983) 0.85
An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs. J Immunol (2001) 0.84
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma. Eur J Immunol (1999) 0.84
Cell membrane polymorphisms coded for in the HLA-D/DR region. I. Relation between D and DR. Hum Immunol (1982) 0.84
HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Clin Genet (1985) 0.83
Association of antibody responses to the 19-kDa antigen of Mycobacterium tuberculosis and the HLA-DQ locus. J Infect Dis (1993) 0.83
Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo. Clin Exp Immunol (1994) 0.83
HLA and susceptibility to cervical neoplasia. Hum Immunol (1999) 0.83
A polygenic model for integration of linkage and pathway information. Genet Epidemiol (2009) 0.83
Mortality rates after heart transplantation: how to compare center-specific outcome data? Transplantation (2003) 0.83
Estimation of individual genetic effects from binary observations on relatives applied to a family history of respiratory illnesses and chronic lung disease of newborns. Biometrics (2000) 0.83
The (in)validity of sensitivity and specificity. Stat Med (2000) 0.83
Multiple epitopes on a single DQ molecule from the DQw3-carrying haplotypes. Tissue Antigens (1986) 0.82
A community based study of the incidence of dementia in subjects aged 85 years and over. J Neurol Neurosurg Psychiatry (1995) 0.82
HLA-DRw6 and renal allograft rejection. Br Med J (Clin Res Ed) (1983) 0.82
HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5. Int J Cancer (1987) 0.82
Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone. Thromb Haemost (1985) 0.81
Excellent outcome after transplantation of renal allografts from HLA-DRw6-positive donors even in HLA-DR mismatches. Lancet (1983) 0.81
Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis. Rheumatology (Oxford) (2001) 0.81
HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study. Hum Immunol (1984) 0.81